ACTIONS OF GROWTH HORMONE-RELEASE INHIBITING HORMONE (SOMATOSTATIN) ON THE RENIN ALDOSTERONE SYSTEM

1 July 1976

journal article
research article
Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism

Vol. 43 (1) , 240-243
https://doi.org/10.1210/jcem-43-1-240

Abstract

Administration of growth hormone-release inhibiting hormone (GH-RIH, somatostatin), as a 90 minute infusion (10 ug/min), to 3 healthy young men under conditions of active renin secretion achieved by pretreatment with furosemide (80 mg daily for 5 days), caused a mean 30% fall in plasma renin activity, which returned to basal levels immediately after stopping the GH-RIH infusion. Plasma aldosterone levels were not affected during the course of this experiment.

Keywords

RENIN
HORMONES
GROWTH
SOMATOSTATIN
INFUSION PROCEDURES
ALDOSTERONE
PLASMA

This publication has 1 reference indexed in Scilit:

Solid phase synthesis of growth hormone-release inhibiting factor
Biochemical and Biophysical Research Communications, 1973